Baker TB - Search Results

1

A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction.

Weiss RB, Baker TB, Cannon DS, von Niederhausern A, Dunn DM, Matsunami N, Singh NA, Baird L, Coon H, McMahon WM, Piper ME, Fiore MC, Scholand MB, Connett JE, Kanner RE, Gahring LC, Rogers SW, Hoidal JR, Leppert MF. Weiss RB, et al. Among authors: baker tb. PLoS Genet. 2008 Jul 11;4(7):e1000125. doi: 10.1371/journal.pgen.1000125. PLoS Genet. 2008. PMID: 18618000 Free PMC article. Clinical Trial.

2

Predicting relapse back to smoking: contrasting affective and physical models of dependence.

Kenford SL, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB. Kenford SL, et al. Among authors: baker tb. J Consult Clin Psychol. 2002 Feb;70(1):216-27. J Consult Clin Psychol. 2002. PMID: 11860048

3

Have we lost our way? The need for dynamic formulations of smoking relapse proneness.

Piasecki TM, Fiore MC, McCarthy DE, Baker TB. Piasecki TM, et al. Among authors: baker tb. Addiction. 2002 Sep;97(9):1093-108. doi: 10.1046/j.1360-0443.2002.00216.x. Addiction. 2002. PMID: 12199822 Review.

4

Effectiveness of a clinic-based strategy for implementing the AHRQ Smoking Cessation Guideline in primary care.

Katz DA, Muehlenbruch DR, Brown RB, Fiore MC, Baker TB; AHRQ Smoking Cessation Guideline Study Group. Katz DA, et al. Among authors: baker tb. Prev Med. 2002 Sep;35(3):293-301. doi: 10.1006/pmed.2002.1073. Prev Med. 2002. PMID: 12202073 Clinical Trial.

5

Effective tobacco dependence treatment.

Fiore MC, Hatsukami DK, Baker TB. Fiore MC, et al. Among authors: baker tb. JAMA. 2002 Oct 9;288(14):1768-71. doi: 10.1001/jama.288.14.1768. JAMA. 2002. PMID: 12365962 No abstract available.

6

Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers.

Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB. Piasecki TM, et al. Among authors: baker tb. J Abnorm Psychol. 2003 Feb;112(1):3-13. J Abnorm Psychol. 2003. PMID: 12653409 Clinical Trial.

7

Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations.

Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB. Piasecki TM, et al. Among authors: baker tb. J Abnorm Psychol. 2003 Feb;112(1):14-27. J Abnorm Psychol. 2003. PMID: 12653410 Clinical Trial.

8

Use of the vital sign stamp as a systematic screening tool to promote smoking cessation.

Piper ME, Fiore MC, Smith SS, Jorenby DE, Wilson JR, Zehner ME, Baker TB. Piper ME, et al. Among authors: baker tb. Mayo Clin Proc. 2003 Jun;78(6):716-22. doi: 10.4065/78.6.716. Mayo Clin Proc. 2003. PMID: 12934781 Clinical Trial.

9

Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity.

Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB. Piasecki TM, et al. Among authors: baker tb. Exp Clin Psychopharmacol. 2003 Nov;11(4):276-85. doi: 10.1037/1064-1297.11.4.276. Exp Clin Psychopharmacol. 2003. PMID: 14599261 Clinical Trial.

10

Transdisciplinary science applied to the evaluation of treatments for tobacco use.

Baker TB, Hatsukami DK, Lerman C, O'Malley SS, Shields AE, Fiore MC. Baker TB, et al. Nicotine Tob Res. 2003 Dec;5 Suppl 1:S89-99. doi: 10.1080/14622200310001625564. Nicotine Tob Res. 2003. PMID: 14668089 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

370 results

Search Page

Filters